![Robert Woods](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Woods
Chief Operating Officer at
SCHOLAR ROCK HOLDING CORPORATION
Net worth: 2 M $ as of 2026-05-30
Profile
Currently, R. Keith Woods holds the position of Chief Operating Officer of argenx SE. In his past career he held the position of SVP-North American Operations at Alexion Pharmaceuticals, Inc. and Vice president & Managing Director at Alexion Pharma UK Ltd. (a subsidiary of Alexion Pharmaceuticals, Inc.). He received an undergraduate degree from Florida State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-15 | 48,034 ( 0.04% ) | 2 M $ | 2026-05-30 | |
| 2025-06-08 | 6,000 ( 0.01% ) | 25 860 $ | 2026-05-30 | |
-.--% | 2026-04-06 | 0 ( -.--% ) | - $ | 2026-05-30 |
| 2026-05-19 | 0 ( -.--% ) | - $ | 2026-05-30 |
Robert Woods active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 2023-12-05 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Operating Officer | 2025-04-26 |
Former positions of Robert Woods
| Companies | Position | End |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 2025-08-21 |
| ROCKET PHARMACEUTICALS, INC. | Chief Operating Officer | 2025-06-17 |
| ARGENX SE | Corporate Officer/Principal | 2023-05-31 |
Alexion Pharma UK Ltd.
 Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Robert Woods
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Distribution Services |
- Stock Market
- Insiders
- Robert Woods
